KY02111
KY02111 is a Wnt signaling pathway inhibitor. KY02111 promotes differentiation of human pluripotent stem cells (hPSC) to cardiomyocytes by inhibiting Wnt signaling in hPSC in a manner that is distinct from that of previously studied Wnt inhibitors. The substantial (98%) differentiation of hPSC to cardiomyocytes with KY02111 is achieved in xeno-free and cytokine-free conditions.
- Datasheet: view or download
Peptides & proteins
1118807-13-8
N-(6-Chloro-2-benzothiazolyl)-3,4-dimethoxybenzenepropanamide
1) Konopleva, M., et al. 2008, Cancer Research. 68(9): 3413-3420. PMID: 18451169; 2) Fan, W., et al. 2011. Cancer Res. 71(13): 4494-4505. PMID: 21555370; 3) Ying, S., et al. 2012. Cancer Res. 72(11): 2814-2821. PMID: 22447567
413.49
-20°C. Keep away from direct sunlight.
12 months from receipt